Drug Discovery · San Francisco, CA · Founded 2000 · Privately Held (backing)
Developer of first-in-class immune-modulators to target diseases of the immune system. AltruBio is based in San Francisco, CA and was founded in 2000. It has raised $337 million across 1 recorded round; the latest was a $225 million Series B in May 2024.
Last price · $/share
—
Implied valuation
—
Total raised
$336.6M
Last round
Later Stage VC (Series B)
May 2024
Team — not yet on record
No current team members for AltruBio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of AltruBio with a free account
·Watch AltruBio: the Monday email on marks, rounds and moves
